Results 221 to 230 of about 607,319 (267)

Quinapril in Chronic Heart Failure

American Journal of Hypertension, 1990
Angiotensin converting enzyme inhibitors are now firmly established in the treatment of patients with chronic heart failure (CHF). Their beneficial acute and chronic hemodynamic effects are not associated with reflex tachycardia or drug tolerance. Angiotensin converting enzyme inhibitors produce symptomatic improvement and improve exercise capacity in ...
D B, Northridge, H J, Dargie
openaire   +2 more sources

Economics of Chronic Heart Failure

European Journal of Heart Failure, 2001
Abstract Chronic heart failure (CHF) is now recognized as a major and escalating public health problem. The costs of this syndrome, both in economic and personal terms, are considerable. The prevalence of CHF is 1–2% and appears to be increasing, in part because of ageing of the population. Economic analyses of CHF should include both
C, Berry, D R, Murdoch, J J, McMurray
openaire   +2 more sources

An overview of chronic heart failure

Nursing Standard, 2023
Heart failure (HF) is associated with high morbidity and mortality and is a significant public health concern. Globally, the prevalence of HF is increasing and prognosis remains suboptimal for people with the condition. HF has significant effects on patients, their families and healthcare services. People with HF can present with acute or chronic signs
Jyoti Shrestha, Sarah Done
openaire   +4 more sources

Chronic Heart Failure

Orthopaedic Nursing, 2022
Chronic heart failure affects over 6 million Americans and is the main reason that people older than 65 years get admitted to the hospital (Centers for Disease Control and Prevention, 2020). Management of heart failure requires interdisciplinary efforts involving primary care physicians, cardiologists, nurses, and pharmacists among other providers ...
Shereen, Salama, Aeman, Choudhury, Sean P, Kane   +2 more
openaire   +2 more sources

Hyponatremia in Chronic Heart Failure

Kardiologiia, 2014
Hyponatremia - lowering of sodium in blood serum below 135 mmol/l - is a frequent disorder of electrolyte metabolism in patients with chronic heart failure (CHF). Hyponatremia is a risk factor of elevated mortality, repetitive hospitalizations, and worsening of kidney function in patients with decompensation of CHF.
D Iu, Shchekochikhin, F Iu, Kopylov, N L, Kozlovskaia, A L, Syrkin   +3 more
openaire   +2 more sources

Chronic Heart Failure

Pediatric Critical Care Medicine, 2016
Objectives: The objectives of this review are to discuss the paradigms used to stage heart failure in children, the classification and physiologic profile of cardiomyopathies, and the acute and chronic pharmacologic management of heart failure. Data Source: MEDLINE, PubMed.
openaire   +2 more sources

Inflammation in Chronic Heart Failure

Annals of Pharmacotherapy, 2008
Objective: To summarize findings regarding the association of inflammatory processes with chronic heart failure (HF). Data Sources: We conducted PubMed/MEDLINE searches (1966–January 2006) of primary literature using the following key ...
Roy C, Parish, Jeffery D, Evans
openaire   +2 more sources

Telomeres and Chronic Heart Failure

Kardiologiia, 2014
With age, a person's cardio-vascular system changes gradually formed at different functional levels, which are the basis for the development of chronic heart failure. While aging itself does not lead to chronic heart failure, it is likely that age-related changes in the human body can accelerate the time onset of signs and symptoms of the disease ...
O M, Drapkina, R N, Shepel'
openaire   +2 more sources

Erythropoietin in Chronic Heart Failure

Congestive Heart Failure, 2007
In patients with chronic heart failure (CHF), anemia is common and is associated with adverse outcome. Correction of anemia by erythropoiesis‐stimulating proteins would thus seem attractive. Endogenous erythropoietin (Epo) levels are increased in CHF and are associated with severity of the disease and with increased mortality.
Anne M S, Belonje, Adriaan A, Voors, Wiek H, van Gilst, Dirk J, van Veldhuisen   +3 more
openaire   +2 more sources

Testosterone in Chronic Heart Failure

2008
Chronic heart failure is common and can be described as a syndrome characterized by impairment of cardiac function associated with a maladaptive metabolic and neurohormonal axis. The thesis that testosterone replacement therapy may be helpful as a treatment for chronic heart failure may seem at first to be unlikely.
C, Malkin, T, Jones, K, Channer
openaire   +2 more sources